Rheumatoid arthritis and hepatitis B virus: Evaluating the pathogenic link

被引：0
|
作者：
Csepregi, A
Nemesanszky, E
Rojkovich, B
Poor, G
机构：
[1] Polyclin Hosp Brothers St John God Budapest, Dept Gastroenterol & Med, H-1027 Budapest, Hungary
[2] Natl Inst Rheumatism & Physiotherapy, Dept Rheumatol & Metab Bone & Joint Dis, Budapest, Hungary
来源：
JOURNAL OF RHEUMATOLOGY | 2001年 / 28卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：474 / 477
页数：4
相关论文
共 50 条
  • [31] Chronic kidney disease and inflammatory cytokines in rheumatoid arthritis: a potential pathogenic link
    Hanaoka, Hironari
    Aoki, Takumi
    Kosaka, Taiji
    Yoshinaga, Shoichi
    Shibata, Akiko
    Sakai, Ryota
    Kurasawa, Takahiko
    Amano, Koichi
    IMMUNOLOGICAL MEDICINE, 2025,
  • [32] B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects
    Wu, Fengping
    Gao, Jinfang
    Kang, Jie
    Wang, Xuexue
    Niu, Qing
    Liu, Jiaxi
    Zhang, Liyun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [33] Pathogenic implication of B cell superantiben in rheumatoid arthritis.
    Hakoda, M
    Kawashima, Y
    Maeda, R
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S163 - S163
  • [34] Tocilizumab for Rheumatoid Arthritis with Chronic Hepatitis B Virus Infection without Antiviral Therapy reply
    Wendling, Daniel
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1066 - 1067
  • [35] Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept
    Germanidis, Georgios
    Hytiroglou, Prodromos
    Zakalka, Marina
    Settas, Loukas
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1420 - 1421
  • [36] Reactivation of Hepatitis B Virus in Patients with Rheumatoid Arthritis after Anti-TNF Therapy
    Jung, Seung Min
    Min, Hong Ki
    Koh, Jung Hee
    Kang, Jin Young
    Lee, Jennifer
    Kwok, Seung-Ki
    Ju, Ji Hyeon
    Ko, Hyeok-Jae
    Park, Kyung-Su
    Kim, Ho-Youn
    Park, Sung-Hwan
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S208 - S208
  • [37] Reply to: Vaccination for hepatitis B virus in an Australian pre-biologic population with rheumatoid arthritis
    Meroni, P.
    Zavaglia, D.
    Girmenia, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (01)
  • [38] Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection
    Padovan, Melissa
    Filippini, Matteo
    Tincani, Angela
    Lanciano, Elisabetta
    Bruschi, Eleonora
    Epis, Oscar
    Garau, Pietro
    Mathieu, Alessandro
    Celletti, Eleonora
    Giani, Leopoldo
    Tomietto, Paola
    Atzeni, Fabiola
    Puttini, Piercarlo Sarzi
    Zuliani, Francesca
    De Vita, Salvatore
    Trotta, Francesco
    Grilli, Anastasio
    Puoti, Massimo
    Govoni, Marcello
    ARTHRITIS CARE & RESEARCH, 2016, 68 (06) : 738 - 743
  • [39] Safety of etanercept treatment in patients with hepatitis B or C virus, and rheumatoid arthritis or ankylosing spondylitis
    Moreno, E
    Erra, A
    Leon, Y
    Tomás, C
    Barceló, P
    Marsal, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 280 - 280
  • [40] TREATMENT AND OUTCOMES OF RHEUMATOID ARTHRITIS PATIENTS WITH HEPATITIS B
    Choi, C. -B.
    Sung, Y. -K.
    Cho, S. -K.
    Yoo, D. -H.
    Lee, S. -S.
    Lee, J.
    Kim, J.
    Lee, H. -S.
    Kim, T. -H.
    Yoon, B. Y.
    Yoo, W. -H.
    Choe, J. -Y.
    Lee, S. -H.
    Shim, S. -C.
    Chung, W. -T.
    Hong, S. -J.
    Lee, C. K.
    Koh, E.
    Jun, J. -B.
    Bang, S. -Y.
    Kim, S. -K.
    Cha, H. -S.
    Won, S.
    Bae, S. -C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 851 - 852
12345